n/a
Abstract Title:

Lactoferrin: a potential candidate to fight respiratory infections in the pandemic COVID-19 era.

Abstract Source:

J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1 Suppl. 2):9-13. PMID: 33982532

Abstract Author(s):

D Passali, V Damiani, F Cianfrone, G C Passali, L M Bellussi, G Ciprandi

Article Affiliation:

D Passali

Abstract:

Respiratory infections are a significant burden at any age, but especially in childhood and aging. The COVID-19 pandemic has worsened the issue since there is no specific treatment and vaccine is not available. Moreover, respiratory symptoms cause social stigma in subjects suffering from an infection of any kind. As new drugs require a very long time to be marketed, a natural compound's interest is growing. In this regard, lactoferrin is a multifunctional protein present in secretions, mainly in breast milk. Lactoferrin has marked antimicrobial activity, including antibacterial, antiviral, antiparasitic, and antifungal. Moreover, lactoferrin strongly affects immune response and cellular control activity. Therefore, this natural component could provide a promising effect in preventing respiratory infections and potentially also for COVID-19.

Study Type : Commentary

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.